指南与共识心血管技术与安全

土耳其心血管外科学会等七学会感染性心内膜炎诊断、治疗与预防共识报告

Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Soc
指南 / 共识 · Turk Gogus Kalp Damar Cerrahisi Derg · 2020-01-23

该共识由土耳其心血管外科学会、临床微生物学与感染性疾病学会、心脏病学会、核医学会、放射学会、牙科协会及病理学会心血管系统研究组联合制定,针对土耳其感染性心内膜炎流行病学、诊断、治疗与预防的现状与本地数据形成共识。文件指出土耳其缺乏基于人群的前瞻性研究,推测发病率较高且患者年轻,病原体鉴定率低于发达国家,部分一线抗菌药物不可及,强调需标准化诊疗流程。

要点

  • 土耳其IE患者多数首诊不能确诊,约半数在三个月后方获诊断,疾病常被漏诊。
  • 土耳其IE病原体鉴定率显著低于发达国家,多数中心未将关键微生物学诊断试验列为常规。
  • 推荐用于IE一线治疗的抗葡萄球菌青霉素等部分抗菌药物在土耳其不可及。

临床应用与阅片要点

  • IE诊断与治疗流程应在每一环节标准化,使多学科医师参与的管理始终符合当前推荐。
  • 应重视IE的早期识别,因多数患者首诊不能确诊且疾病常被漏诊。
  • 应关注土耳其病原体鉴定率偏低及关键微生物学诊断试验未常规开展的问题。

局限性

  • 土耳其缺乏基于人群的前瞻性研究,IE发病率估计受限。
  • 土耳其IE病原体鉴定率显著低于发达国家。
  • 多数中心未将部分关键微生物学诊断试验作为常规实践。
  • 部分推荐为IE一线治疗的抗菌药物,特别是抗葡萄球菌青霉素,在土耳其不可及。
  • 原文指出IE在土耳其仍影响年轻人,而在发达国家通常影响老年人。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Infective endocarditis (IE) is rare, but associated with significant morbidity and mortality rates. Estimates of the incidence of IE in Turkey are compromised by the absence of population-based prospective studies. Due to the frequent presence of predisposing cardiac conditions and higher rates of nosocomial bacteremia in highrisk groups, the incidence of IE is expected to be higher in Turkey. Additionally, while IE generally affects older people in developed countries, it still affects young people in Turkey. In order to reduce the mortality and morbidity, it is critical to diagnose the IE to determine the causative agent and to start treatment rapidly. However, most of the patients cannot be diagnosed in their first visits, about half of them can be diagnosed after three months, and the disease often goes unnoticed. In patients diagnosed with IE, the rate of identification of causative organisms is significantly lower in Turkey than in developed countries. Furthermore, most of the centers do not perform some essential microbiological diagnostic tests as a routine practice. Some antimicrobials that are recommended as the first-line of treatment for IE, particularly antistaphylococcal penicillins, are not available in Turkey. These problems necessitate reviewing the epidemiological, laboratory, and clinical characteristics of IE in our country, as well as the current information about its diagnosis, treatment, and prevention together with local data. Physicians can follow patients with IE in many specialties. Diagnosis and treatment processes of IE should be standardized at every stage so that management of IE, a setting in which many physicians are involved, can always be in line with current recommendations. Study Group for Infective Endocarditis and Other Cardiovascular Infections of the Turkish Society of Clinical Microbiology and Infectious Diseases has called for collaboration of the relevant specialist organizations to establish a consensus report on the diagnosis, treatment, and prevention of IE in the light of current information and local data in Turkey.

来源:Turk Gogus Kalp Damar Cerrahisi Derg,查看原文。版权归原作者所有。

引用

  1. Şimşek-Yavuz S, Akar AR, Aydoğdu S, et al. Consensus Report on Diagnosis, Treatment and Prevention of Infective Endocarditis by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK), Turkish Society of Cardiology (TSC), Turkish Society of Nuclear Medicine (TSNM), Turkish Society of Radiology (TSR), Turkish Dental Association (TDA) and Federation of Turkish Pathology Societies (TURKPATH) Cardiovascular System Study Group. Turk Gogus Kalp Damar Cerrahisi Derg. 2020. PMID: 32175140. doi:10.5606/tgkdc.dergisi.2020.01954

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。